Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$962M |
| 2 |
Cisco
CSCO
|
$202M |
| 3 |
Amazon
AMZN
|
$165M |
| 4 |
Johnson & Johnson
JNJ
|
$153M |
| 5 |
Pinduoduo
PDD
|
$131M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$468M |
| 2 |
Merck
MRK
|
$306M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$305M |
| 4 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
$299M |
| 5 |
TRTN
Triton International Limited
TRTN
|
$282M |
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Financials | 17.12% |
| 3 | Industrials | 13% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Pathfinder Bancorp
PBHC
$92.3M
| $228K | ﹤0.01% |
16,497
| – | – |
|
3177
Kingsway Financial Services
KFS
$411M
| $228K | ﹤0.01% |
27,095
| – | – |
|
3178
Oric Pharmaceuticals
ORIC
$1.05B
| $227K | ﹤0.01% |
24,676
-16
| -0.1% | -$147 |
|
3179
Personalis
PSNL
$451M
| $226K | ﹤0.01% |
107,562
-109,776
| -51% | -$231K |
|
3180
Adtran
ADTN
$774M
| $226K | ﹤0.01% |
30,723
-41,390
| -57% | -$304K |
|
3181
Viridian Therapeutics
VRDN
$1.52B
| $219K | ﹤0.01% |
10,070
| – | – |
|
|
TOUR
3182
Tuniu
TOUR
$104M
| $219K | ﹤0.01% |
321,634
-22,856
| -7% | -$15.5K |
|
3183
fuboTV
FUBO
$1.29B
| $216K | ﹤0.01% |
67,931
+3,254
| +5% | +$10.4K |
|
3184
First National Corp
FXNC
$210M
| $215K | ﹤0.01% |
+9,877
| New | +$215K |
|
|
CMCT
3185
Creative Media & Community Trust
CMCT
$5.72M
| $214K | ﹤0.01% |
234
| – | – |
|
3186
Acumen Pharmaceuticals
ABOS
$84.2M
| $214K | ﹤0.01% |
55,791
-19,811
| -26% | -$76.1K |
|
3187
Root
ROOT
$1.45B
| $212K | ﹤0.01% |
20,268
+1,778
| +10% | +$18.6K |
|
3188
PDS Biotechnology
PDSB
$56.9M
| $210K | ﹤0.01% |
42,164
-1,978
| -4% | -$9.83K |
|
3189
Annovis Bio
ANVS
$44.4M
| $207K | ﹤0.01% |
11,095
-11,491
| -51% | -$215K |
|
3190
Bank Of The James
BOTJ
$70M
| $207K | ﹤0.01% |
17,244
| – | – |
|
3191
Ouster
OUST
$1.64B
| $204K | ﹤0.01% |
+26,587
| New | +$204K |
|
3192
Kingstone Companies
KINS
$204M
| $203K | ﹤0.01% |
95,036
-8,064
| -8% | -$17.2K |
|
3193
Zynex
ZYXI
$45.1M
| $201K | ﹤0.01% |
18,426
+5
| +0% | +$54 |
|
|
ATYR
3194
aTyr Pharma
ATYR
$536M
| $201K | ﹤0.01% |
142,248
-94,201
| -40% | -$133K |
|
3195
Avalon Holdings
AWX
$9.65M
| $200K | ﹤0.01% |
83,772
-2,858
| -3% | -$6.83K |
|
3196
Zedge
ZDGE
$40.6M
| $200K | ﹤0.01% |
85,083
| – | – |
|
3197
Gevo
GEVO
$394M
| $199K | ﹤0.01% |
171,407
| – | – |
|
|
LBPH
3198
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $198K | ﹤0.01% |
32,747
+20,359
| +164% | +$123K |
|
3199
Willamette Valley Vineyards
WVVI
$21.9M
| $198K | ﹤0.01% |
37,324
-1,581
| -4% | -$8.38K |
|
3200
Cricut
CRCT
$1.25B
| $197K | ﹤0.01% |
29,896
+11,883
| +66% | +$78.3K |
|